•
Plans
Accident & Emergency Cover: Limited Value, Structural Constraints, and the Case for Clarity
Chapter Three - Previous Chapter
Introduction: transparency forces the question
Chapters 1 and 2 established that as pricing becomes transparent:
every component of a dental membership must stand on its own merit.
Historically, A&E (Accident & Emergency) cover has been included as part of bundled plans, rarely questioned and often poorly understood.
That is no longer sustainable.
As practices begin to separate:
administration fees
scheme components
and true cost drivers
A&E becomes one of the first elements to be scrutinised.
The core issue: A&E has limited real-world value
At its core, A&E appears attractive:
low monthly cost (~£0.50–£0.60)
protection against unexpected events
However, in practice:
A&E applies in very few real-world scenarios.
This is not incidental.
It is a direct result of how the product is designed.
Coverage limitations: why A&E rarely applies
Across both:
insurance-based products (e.g. Denplan)
and discretionary schemes (Practice Plan, DPAS, Patient Plan Direct, Tabeo, others)
A&E cover is defined by what it excludes.
Common exclusions and constraints include:
sport-related injuries (one of the most common causes of dental trauma)
damage while eating (e.g. biting on hard food)
incidents occurring near the patient’s home (e.g. within ~20 miles)
treatment delivered by the patient’s own practice
Taken together, these exclusions remove a large share of situations in which dental damage actually occurs.
A product that sounds broad but is narrow
This creates a fundamental mismatch:
A&E is perceived as broad protection
but operates as a narrowly defined cover
In reality:
it only applies to a small subset of edge-case scenarios.
The consequence: extremely low utilisation
Because applicability is so constrained:
only a very small proportion of members ever claim
In practical terms: ~1 in 400 to 1 in 500 members may claim in a given year
Graph request
A&E applicability vs perception
Dimension | Reality |
Perceived coverage | Broad |
Actual applicability | Narrow |
Annual claim rate | ~0.2%–0.25% |
Over 5-year period: only a small minority of patients will ever use the cover. This explains the economics.
Why A&E is priced the way it is
A&E appears inexpensive. But this is not because it delivers high value efficiently. It is because:
claims are rare
coverage is limited
and payouts are tightly controlled
A&E is cheap because it rarely applies.
Limited value to the practice
A&E also delivers limited value to the practice itself.
In most cases:
treatment is provided outside the patient’s regular practice
the practice does not capture revenue from claims
This means A&E:
does not strengthen the patient relationship
does not drive in-practice activity
and sits largely outside the core care model.
Consistency across the market
Importantly, this is not specific to one provider.
Across:
Denplan
Practice Plan / DPAS
Patient Plan Direct
Agilio
Tabeo
the structure is broadly consistent:
similar exclusions
similar claim frequency
similar economic profile
Differences exist at the margins, but the underlying model is the same.
Structural ambiguity: neither insurance nor care
A&E sits in an unclear position:
it resembles insurance
but is often delivered as a discretionary scheme
This creates two issues:
1. Lack of clarity for consumers
Discretionary schemes:
are not regulated as insurance
do not require standardised disclosure
and may retain discretion over payouts
This means:
patients may not fully understand what is covered — or not covered.
2. Weak alignment with care delivery
At the same time:
A&E is not integrated into the practice’s care model
and does not reinforce ongoing treatment or engagement
It sits between:
protection
and service
without fully delivering either.
Why this strengthens the case for regulation
Given these limitations, the structure of A&E becomes more important.
If a product:
has significant exclusions
applies only in edge cases
and is positioned as protection
then:
clarity becomes critical.
This is where regulation plays a role.
A clearer model: insurance or embedded care
As the market evolves, A&E is likely to move toward one of two models:
Option 1: Regulated insurance
clear disclosures
defined coverage
contractual certainty
This ensures that:
patients understand limitations
and protection is explicit.
Option 2: Embedded care
no separate A&E product
emergency care included within membership
This aligns:
patient experience
and practice delivery.
What becomes difficult to sustain
Between these two, the current model becomes harder to justify:
discretionary schemes that resemble insurance but lack its clarity and protection.
Implications for repricing
This has a direct impact on pricing (Chapter 2).
As A&E is:
unbundled
questioned
or removed
it contributes to: downward pressure on total plan pricing
and reduces a historically stable revenue component for incumbents.
Implications for incumbents
This does not eliminate incumbents from the value chain.
A natural evolution is:
to act as distributors of regulated insurance
rather than structuring discretionary schemes
This preserves:
distribution capability
while improving transparency.
Implications for practices
For practices, A&E becomes an explicit decision:
Is it worth including?
Does it deliver meaningful value?
Or should emergency care be integrated directly?
This shifts A&E from:
default inclusion
to:
deliberate choice
Transition: from removing complexity to driving growth
If Chapter 3 focuses on:
what is being stripped back or redefined
the next question becomes:
what replaces it as a driver of growth?
As legacy components like A&E are questioned or removed, growth becomes:
more intentional
more operational
and more dependent on execution.
Looking ahead
Chapter 4 explores:
how practices actually grow memberships — through NHS conversion, patient segmentation, and structured execution
and how this replaces passive, bundled growth with active, system-driven expansion.
Final takeaway
A&E is not disappearing — but its current form is increasingly difficult to justify.
it is a low-frequency, highly constrained product that becomes exposed under transparency
The market is moving toward:
clearer definitions
simpler structures
and more explicit value.